title: How the genomics revolution could finally help Africa.
authors.forename: Linda
authors.initials: L
authors.lastname: Nordling
mesh_terms: D000349:Africa / Q000453:epidemiology / Q000208:ethnology; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D000075944:Apolipoprotein L1; D001053:Apolipoproteins / Q000235:genetics; D048588:Benzoxazines / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D044383:Black People / Q000235:genetics*; D002608:Charities / Q000191:economics; D003521:Cyclopropanes; D003924:Diabetes Mellitus, Type 2 / Q000453:epidemiology / Q000235:genetics; D020022:Genetic Predisposition to Disease; D005826:Genetics, Medical / Q000191:economics / Q000639:trends*; D055106:Genome-Wide Association Study / Q000706:statistics & numerical data; D023281:Genomics / Q000191:economics / Q000639:trends*; D015658:HIV Infections / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics; D006575:Heterocyclic Compounds, 3-Ring / Q000627:therapeutic use; D006801:Humans; D007674:Kidney Diseases / Q000191:economics / Q000453:epidemiology / Q000235:genetics / Q000628:therapy; D008075:Lipoproteins, HDL / Q000235:genetics; D009316:National Institutes of Health (U.S.) / Q000191:economics; D009369:Neoplasms / Q000235:genetics / Q000532:radiotherapy / Q000628:therapy; D010078:Oxazines; D010879:Piperazines; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D057285:Precision Medicine / Q000191:economics / Q000639:trends*; D011634:Public Health / Q000191:economics / Q000639:trends*; D011728:Pyridones; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D020521:Stroke / Q000453:epidemiology / Q000235:genetics; D014353:Trypanosomiasis, African / Q000453:epidemiology / Q000235:genetics; D014481:United States; D044465:White People / Q000235:genetics; D001741:Black or African American; D000099226:Dolutegravir
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D000075944:Apolipoprotein L1; D001053:Apolipoproteins; D048588:Benzoxazines; D003521:Cyclopropanes; D006575:Heterocyclic Compounds, 3-Ring; D008075:Lipoproteins, HDL; D010078:Oxazines; D010879:Piperazines; D011728:Pyridones; D018894:Reverse Transcriptase Inhibitors; D000099226:Dolutegravir; C108666:APOL1 protein, human; C098320:efavirenz